Edema of the pulmonary interstitium in infants and children

Area of Science:

• Pediatric Critical Care
• Pulmonology
• Pharmacology

Background:

• Respiratory failure in infants and children often requires ventilatory support.
• Impaired water tolerance can exacerbate pulmonary conditions during mechanical ventilation.
• Interstitial pulmonary edema may complicate lung disease and ventilation management.

Purpose of the Study:

• To evaluate the efficacy of intravenous furosemide in improving oxygenation in pediatric patients with respiratory failure.
• To assess the impact of furosemide on gas exchange parameters in this patient population.
• To investigate the role of furosemide in managing pulmonary edema associated with respiratory failure.

Main Methods:

• Ten infants and children with respiratory failure received intravenous furosemide (1-2 mg/kg).
• Patients were monitored for changes in oxygenation (Po2) and carbon dioxide (Pco2) levels.
• Urine output was measured to assess diuretic response.

Main Results:

• Furosemide administration led to a five-fold increase in urine output.
• Mean Po2 increased from 61 mm Hg (at FiO2 0.7) to 140 mm Hg (at FiO2 0.65).
• Mean Pco2 decreased from 46 mm Hg to 38 mm Hg.

Conclusions:

• Intravenous furosemide is effective in improving oxygenation and reducing hypercapnia in pediatric patients with respiratory failure and pulmonary edema.
• Diuretic therapy can mitigate the effects of impaired water tolerance during mechanical ventilation.
• Furosemide should be considered in managing interstitial pulmonary edema in critically ill children with respiratory compromise.